Structural development studies of anti-hepatitis C virus agents with a phenanthridinone skeleton
- PMID: 20303772
- DOI: 10.1016/j.bmc.2010.02.057
Structural development studies of anti-hepatitis C virus agents with a phenanthridinone skeleton
Abstract
A phenanthridinone skeleton was derived from our previous researches on thalidomide and retinoids as a multi-template for generation of anti-viral lead compounds. Structural development studies focusing on anti-hepatitis C virus activity afforded 5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenanthridin-6(5H)-one (10) and 5-butylbenzo[b]phenanthridin-6(5H)-one (39), which showed EC(50) values of approximately 3.7 and 3.2microM, respectively.
Copyright 2010 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources